Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal cell carcinoma.

Brian I Rini1, Steven C Campbell, W Kimryn Rathmell

  • 1Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.

Current Opinion in Oncology
|March 23, 2006
PubMed
Summary

Recent advancements in renal cell carcinoma (RCC) treatment include novel anti-angiogenesis and immunotherapeutics. New targeted therapies and surgical approaches are revolutionizing care for both localized and metastatic RCC.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

Nature·2026
Same author

Podcast on the Emerging Role of PD-(L)1/VEGF Bispecific Antibodies in the Evolving Advanced Renal Cell Carcinoma Treatment Landscape.

Oncology and therapy·2026
Same author

Comprehensive Genomic and Transcriptomic Characterization of Matched Primary and Recurrent Tumors in High-risk Localized Renal Cell Carcinoma.

European urology·2026
Same author

Cardiac biomarkers in patients with renal cell carcinoma treated with immune checkpoint inhibitors.

The oncologist·2026
Same author

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0.

Journal for immunotherapy of cancer·2026
Same author

Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization.

Nature reviews. Clinical oncology·2026

Area of Science:

  • Oncology
  • Urology
  • Nephrology

Background:

  • Renal cell carcinoma (RCC) is a growing disease with evolving treatment landscapes.
  • Understanding the epidemiology and molecular underpinnings of RCC is crucial for effective management.

Purpose of the Study:

  • To review recent novel contributions to renal cell carcinoma (RCC) treatment.
  • To update advances in diagnostic, imaging, and surgical modalities for RCC.
  • To explore dietary and environmental factors in RCC epidemiology.

Main Methods:

  • Review of recent literature on RCC treatment strategies.
  • Analysis of advancements in targeted therapeutics and immunotherapies.
  • Examination of emerging minimally invasive surgical techniques.

Main Results:

  • Innovative treatments have significantly impacted localized and metastatic RCC management.
  • New targeted therapeutics show benefit in the metastatic setting.
  • Groundbreaking strategies are revolutionizing metastatic RCC care.

Conclusions:

  • The management of metastatic RCC has been revolutionized by diverse therapeutic modalities.
  • Emerging data influences the approach to small, localized renal tumors.
  • Diet and tobacco exposure are identified as etiologic factors; targeted therapies and minimally invasive options are advancing.

Related Experiment Videos